Luthringer Remy 4
4 · Minerva Neurosciences, Inc. · Filed Dec 18, 2018
Insider Transaction Report
Form 4
Luthringer Remy
EVP and Head of R&D
Transactions
- Exercise/Conversion
Common Stock
2018-12-14+18,750→ 35,306 total - Sale
Common Stock
2018-12-17$7.46/sh−2,604$19,426→ 32,702 total - Exercise/Conversion
Restricted Stock Unit
2018-12-14−18,750→ 37,500 total→ Common Stock (18,750 underlying)
Holdings
- 926,604(indirect: By Wint2felden Holding SA)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F3]Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.